DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

35.12 1.92 (5.78%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACAD $35.12 5.78%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.69
Previous Close $33.20
Daily Range $32.13 - $35.24
52-Week Range $22.04 - $51.99
Market Cap $3.5B
P/E Ratio -24.78
Dividend (Yield) $0.00 (0.0%)
Volume 1,880,493
Average Daily Volume 1,359,154
Current FY EPS -$1.52




Drug Makers

ACADIA Pharmaceuticals, Inc. (ACAD) Description

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website:

News & Commentary

3 Healthcare Stocks That Could Add a Spark to Your Portfolio

Looking to give your portfolio a jolt? Consider investing in these three spicy healthcare names.

Stock Movement Prior To Phase III Trial Releases: Penny Stocks Rise While Big Stocks Fall

Oversold Conditions For Acadia Pharmaceuticals (ACAD)

5 Sell-Ranked Biotechs That Fell More Than 5% Today

Water-Logged And Getting Wetter: ACADIA Pharmaceuticals (ACAD)

Amgen And Biogen Lead Short Interest Surge In Biotechs

The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA

Perilous Reversal Watch: ACADIA Pharmaceuticals (ACAD)

Premarket Biotech Digest: Shorts Targeting Biotech, Anavex's Promise, Zarxio Launch

Why Parkinson's Disease-Focused ACADIA Pharmaceuticals is Soaring Today

The company officially submitted a New Drug Application to the FDA for its lead compound Nuplazid, and investors cheered the news.

See More ACAD News...

ACAD's Top Competitors

ACAD $35.12 (5.78%)
Current stock: ACAD
AMGN $142.47 (1.60%)
Current stock: AMGN
GILD $98.28 (0.01%)
Current stock: GILD
BIIB $290.35 (1.06%)
Current stock: BIIB